This one day unique key industry event brings together regional governments with international investors and corporate decision makers from European pharmaceutical companies to discuss latest incentives, laws and market drivers that are influencing Central and Southeast Europe as the region with the highest growth in Europe.

Together they will highlight latest legalisation development, pricing strategies and investment possibilities in region, as well as to evaluate current marketing and sales strategies that would maintain growth. The conference provides supreme networking opportunities for delegates to meet with high level representatives from governments and well established pharmaceutical companies. To equip you with a good understanding of the changing regulatory framework, ensuring you are up to date with the latest policies affecting you and your business in the region, this is a conference you cannot afford to miss.





Key topics to be discussed:

• Current situation of the pharmaceutical market and legislative in the countries in the region
• Incorporation of the EU legislative in the national laws
• Implementation of the New Medicines Legislation in the CSEE
• The Growth of Generics in CSEE: Successfully Registering Generic Products
• Experience with the Clinical Trials Directive in the CSEE
• Key Issues in Pricing & Reimbursement Systems in Europe
• Pharmacoeconomics in the Pricing and Reimbursement Context
• Building Company through Collaborations, Partnerships, Acquisitions and Ventures
• Determining the Optimal Sales Force Structure to Ensure Growth in Return of Investment
• Pharmacovigilance – surveillance of the safety of a medicinal product during its life on the market
• Implementing Good Manufacturing Practice (GMP) Standards
• Clinical Trials: Regulatory View
• The Importance of Good Clinical Practice (GCP) in Conducting Clinical Trials

Some of the speakers include:

• Ministry of Health, Romania
• Ministry of Health, Slovak Republic
• Dr. Tamas L. Paal, Ministry of Health, Hungary
• Mrs. Rodica Badescu, National Medicines Agency, Romania
• Mr. Dan Nicolae Zaharescu, Executive Director, ARPIM
• Mrs. Ioana Filipescu, Managing Director, Raiffeisen Investment AG
• Mr. Daniel Popescu, Manager Corporate Affairs, Eli Lilly Romania srl.
• Mr. Heinz Kobelt, European Association of Euro-Pharmaceutical Companies
• Dr. Oliver Popescu, Abbott Laboratories S.A., Romania
• Mr. Petre Mitrea, MD, Product Manager PYXIS Products, Medist SA
• Astra Zeneca
• European Commission – DG Enterprise and Industry
• Pfizer, Romania
• Matrix Contract Research ltd.
• CSC Pharmaceuticals, Romania